"Was it revealed that the outcome data was no different in the statin used?"

Subgroup event rates. Atorvastatin subgroup actually had better absolute and relative risk reduction.

Rosuvastatin, apabetalone vs. placebo: 10.5% vs. 12.1%

Atorvastatin, apabetalone vs. placebo: 10.1% vs. 12.6%